Literature DB >> 28360612

Body Image, Self-Esteem and Depressive Symptomatology in Women with Polycystic Ovary Syndrome.

Bilge Burçak Annagür1, Aybike Tazegül2, Nursel Akbaba1.   

Abstract

INTRODUCTION: In the current study we aimed to determine body image, self-esteem and depressive symptomatology in women with Polycystic ovary syndrome (PCOS) and compare with healthy controls.
METHOD: This study was conducted among the patients with untreated PCOS who admitted to the Outpatient Clinic of Gynecology and Obstetrics of Faculty of Medicine of Selçuk University. A total 83 consecutive women with PCOS met the criteria of present study were included in the study. Age matched healthy controls (n=64) were recruited from employees at Selçuk University Hospital. PCOS was defined according to Rotterdam criteria. After socio-demographic characteristics of the participants were recorded, Body Image Scale, Rosenberg Self-Esteem Scale and Beck Depression Inventory were completed by the participants.
RESULTS: Patients with PCOS and healthy controls did not differ in some sociodemographic variables, including age, education and economic status (p>.05). Previous psychiatric history was more prevalent among the PCOS group (p<. 05). Body mass index (BMI) was ≤25 kg/m2 in both groups. BMI values in the PCOS group were significantly higher than in the controls (p<.05). BDI scores were significantly higher in the PCOS group compared to that in the healthy controls (p<.05). There was no significant difference between the PCOS group and healthy controls in BIS and RSES scores (p>.05).
CONCLUSION: The present study suggests that PCOS seems to be associated with depressive symptomatology. Furthermore, rising BMI values of these women may be an indicator for the onset of PCOS. However, these results should be confirmed by prospective studies.

Entities:  

Keywords:  Body image; PCOS; depression; self esteem

Year:  2014        PMID: 28360612      PMCID: PMC5353087          DOI: 10.4274/npa.y6778

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  22 in total

1.  The appraisal of body-cathexis: body-cathexis and the self.

Authors:  P F SECORD; S M JOURARD
Journal:  J Consult Psychol       Date:  1953-10

2.  Psychological well-being and sexarche in women with polycystic ovary syndrome.

Authors:  J E de Niet; C M de Koning; H Pastoor; H J Duivenvoorden; O Valkenburg; M J Ramakers; J Passchier; C de Klerk; J S E Laven
Journal:  Hum Reprod       Date:  2010-03-31       Impact factor: 6.918

3.  Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression.

Authors:  B Weber; S Lewicka; M Deuschle; M Colla; I Heuser
Journal:  Psychoneuroendocrinology       Date:  2000-11       Impact factor: 4.905

4.  Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women.

Authors:  Lisa M Pastore; James T Patrie; Wendy L Morris; Parchayi Dalal; Megan J Bray
Journal:  J Psychosom Res       Date:  2011-03-23       Impact factor: 3.006

5.  Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.

Authors:  S A Arslanian; V D Lewy; K Danadian
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

Review 6.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

7.  Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36).

Authors:  Sean Coffey; Gul Bano; Helen D Mason
Journal:  Gynecol Endocrinol       Date:  2006-02       Impact factor: 2.260

8.  Women with polycystic ovary syndrome are often depressed or anxious--a case control study.

Authors:  Mattias Månsson; Jan Holte; Kerstin Landin-Wilhelmsen; Eva Dahlgren; Anette Johansson; Mikael Landén
Journal:  Psychoneuroendocrinology       Date:  2008-07-30       Impact factor: 4.905

9.  Quality of life and psychological well being in polycystic ovary syndrome.

Authors:  L Barnard; D Ferriday; N Guenther; B Strauss; A H Balen; L Dye
Journal:  Hum Reprod       Date:  2007-05-30       Impact factor: 6.918

10.  Disturbed stress responses in women with polycystic ovary syndrome.

Authors:  S Benson; P C Arck; S Tan; S Hahn; K Mann; N Rifaie; O E Janssen; M Schedlowski; S Elsenbruch
Journal:  Psychoneuroendocrinology       Date:  2009-01-15       Impact factor: 4.905

View more
  6 in total

1.  The effect of deformity correction on psychiatric condition of the adolescent with adolescent idiopathic scoliosis.

Authors:  Altuğ Duramaz; Semra Yılmaz; Nezih Ziroğlu; Burcu Bursal Duramaz; Tayfun Kara
Journal:  Eur Spine J       Date:  2018-05-25       Impact factor: 3.134

2.  Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety.

Authors:  Snigdha Alur-Gupta; Anat Chemerinski; Chang Liu; Jenna Lipson; Kelly Allison; Mary D Sammel; Anuja Dokras
Journal:  Fertil Steril       Date:  2019-08-05       Impact factor: 7.329

3.  Confirmatory factor analysis and psychometric properties of the Persian version of the Multidimensional Body-Self Relations Questionnaire-Appearance Scales (MBSRQ-AS) in women with polycystic ovary syndrome.

Authors:  Seyedeh Batool Hasanpoor-Azghady; Leila Amiri-Farahani; Roghayeh Arbabi-Moghadam
Journal:  Eat Weight Disord       Date:  2021-05-07       Impact factor: 4.652

4.  Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation.

Authors:  Michael J Boivin; Farnaz Fatehi; Amy E Phillips-Chan; Julia R Richardson; Amanda N Summers; Steven A Foley
Journal:  BMC Womens Health       Date:  2020-06-23       Impact factor: 2.809

5.  Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial.

Authors:  Geranne Jiskoot; Alexandra Dietz de Loos; Annemerle Beerthuizen; Reinier Timman; Jan Busschbach; Joop Laven
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

Review 6.  Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone.

Authors:  Lindsay R Standeven; Elizabeth Olson; Nicole Leistikow; Jennifer L Payne; Lauren M Osborne; Liisa Hantsoo
Journal:  Curr Psychiatry Rep       Date:  2021-04-21       Impact factor: 5.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.